NEOS Investment Management LLC raised its stake in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 13.7% in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 144,623 shares of the semiconductor company's stock after buying an additional 17,443 shares during the quarter. NEOS Investment Management LLC owned about 0.08% of Synopsys worth $64,512,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. Brighton Jones LLC increased its holdings in Synopsys by 5.7% during the 4th quarter. Brighton Jones LLC now owns 921 shares of the semiconductor company's stock worth $447,000 after acquiring an additional 50 shares during the period. Integrated Wealth Concepts LLC boosted its holdings in Synopsys by 11.6% in the 1st quarter. Integrated Wealth Concepts LLC now owns 760 shares of the semiconductor company's stock valued at $326,000 after purchasing an additional 79 shares during the period. NewEdge Advisors LLC boosted its holdings in Synopsys by 15.1% in the 1st quarter. NewEdge Advisors LLC now owns 3,010 shares of the semiconductor company's stock valued at $1,291,000 after purchasing an additional 395 shares during the period. WINTON GROUP Ltd grew its position in shares of Synopsys by 9.2% during the 2nd quarter. WINTON GROUP Ltd now owns 758 shares of the semiconductor company's stock valued at $389,000 after purchasing an additional 64 shares in the last quarter. Finally, Treasurer of the State of North Carolina increased its holdings in shares of Synopsys by 2.1% in the second quarter. Treasurer of the State of North Carolina now owns 72,095 shares of the semiconductor company's stock worth $36,962,000 after purchasing an additional 1,505 shares during the period. 85.47% of the stock is currently owned by institutional investors.
Wall Street Analyst Weigh In
A number of equities research analysts recently issued reports on the company. BNP Paribas Exane increased their price objective on Synopsys from $425.00 to $450.00 and gave the stock an "underperform" rating in a research report on Thursday, May 28th. Morgan Stanley reduced their target price on Synopsys from $525.00 to $500.00 and set an "equal weight" rating for the company in a research report on Wednesday, August 19th. Stifel Nicolaus upped their target price on Synopsys from $550.00 to $600.00 and gave the stock a "buy" rating in a research note on Thursday, May 28th. KeyCorp reaffirmed an "overweight" rating on shares of Synopsys in a report on Wednesday, August 19th. Finally, Piper Sandler upgraded Synopsys from a "neutral" rating to an "overweight" rating and lifted their price target for the company from $450.00 to $550.00 in a research report on Tuesday, June 23rd. Twelve equities research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $561.28.
Read Our Latest Report on SNPS
Insider Transactions at Synopsys
In related news, insider Aart de Geus sold 25,000 shares of the firm's stock in a transaction dated Monday, August 31st. The stock was sold at an average price of $441.76, for a total transaction of $11,044,000.00. Following the transaction, the insider directly owned 120,421 shares of the company's stock, valued at approximately $53,197,180.96. This trade represents a 17.19% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Shelagh Glaser sold 3,394 shares of the business's stock in a transaction that occurred on Friday, June 12th. The stock was sold at an average price of $450.02, for a total value of $1,527,367.88. Following the completion of the sale, the chief financial officer owned 14,358 shares of the company's stock, valued at $6,461,387.16. The trade was a 19.12% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders sold 92,638 shares of company stock worth $40,747,732. 0.56% of the stock is currently owned by corporate insiders.
Synopsys Stock Performance
Synopsys stock opened at $416.31 on Friday. Synopsys, Inc. has a fifty-two week low of $366.00 and a fifty-two week high of $615.79. The company has a debt-to-equity ratio of 0.29, a quick ratio of 1.24 and a current ratio of 1.34. The stock has a market cap of $79.78 billion, a P/E ratio of 73.55, a price-to-earnings-growth ratio of 2.28 and a beta of 1.23. The firm's fifty day moving average price is $413.48 and its 200-day moving average price is $439.79.
Synopsys (NASDAQ:SNPS - Get Free Report) last announced its earnings results on Wednesday, August 26th. The semiconductor company reported $3.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.67 by $0.24. The company had revenue of $2.48 billion during the quarter, compared to analyst estimates of $2.44 billion. Synopsys had a net margin of 11.43% and a return on equity of 6.24%. The firm's quarterly revenue was up 42.4% compared to the same quarter last year. During the same period in the previous year, the business earned $3.39 earnings per share. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. On average, equities research analysts expect that Synopsys, Inc. will post 10.97 earnings per share for the current fiscal year.
Synopsys Company Profile
(
Free Report)
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Recommended Stories
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.